Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease ; volume:19 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-24 ; date:12.2024
Molecular neurodegeneration ; 19, Heft 1 (6.8.2024), 1-24, 12.2024
- Urheber
-
Shantaraman, Anantharaman
Dammer, Eric B.
Ugochukwu, Obiadada
Duong, Duc M.
Yin, Luming
Carter, E. Kathleen
Gearing, Marla
Chen-Plotkin, Alice
Lee, Edward B.
Trojanowski, John Q.
Bennett, David A.
Lah, James J.
Levey, Allan I.
Seyfried, Nicholas T.
Higginbotham, Lenora
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-024-00749-1
- URN
-
urn:nbn:de:101:1-2412302107440.890432619619
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shantaraman, Anantharaman
- Dammer, Eric B.
- Ugochukwu, Obiadada
- Duong, Duc M.
- Yin, Luming
- Carter, E. Kathleen
- Gearing, Marla
- Chen-Plotkin, Alice
- Lee, Edward B.
- Trojanowski, John Q.
- Bennett, David A.
- Lah, James J.
- Levey, Allan I.
- Seyfried, Nicholas T.
- Higginbotham, Lenora
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease